JSS Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Nxera Pharma Co Ltd

Watchlist Manager

Watchlist

Price: 4.66 EUR Market Closed

Market Cap: €720.1m

N	Nxera Pharma Co Ltd SWB:JSS	JP
H	Howmet Aerospace Inc F:48Z	US
	Hilan Ltd OTC:HLTEF	IL
	Galenica AG F:G70	CH
P	Pdz Holdings Bhd KLSE:PDZ	MY
	Bank Amar Indonesia Tbk PT IDX:AMAR	ID

Profitability Summary

Nxera Pharma Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

76%

Strong 3Y Average Gross Margin

74%

Declining Gross Margin

88% > 76%

Negative Operating Margin

-11%

Negative 3Y Average Operating Margin

-30%

Operating Margin is Increasing

-32% > -11%

Negative Net Margin

-23%

Negative 3Y Average Net Margin

-29%

Net Margin is Increasing

-27% > -23%

Negative Free Cash Flow Margin

-14%

Negative 3Y Average Free Cash Flow Margin

-26%

Declining Free Cash Flow Margin

0% > -14%

Negative ROE

-12%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-6%

ROIC is Increasing

-5% > -3%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

76%

Strong 3Y Average Gross Margin

74%

Declining Gross Margin

88% > 76%

Negative Operating Margin

-11%

Negative 3Y Average Operating Margin

-30%

Operating Margin is Increasing

-32% > -11%